Residual Disease After Neoadjuvant Chemotherapy for Breast Cancer

被引：1
|
作者：
Morris, Gloria J. [1 ]
Robinson, Patricia A. [2 ]
Lo, Shelly
Samuel, Thomas A. [3 ]
Sheikh, Asad A. [4 ]
Jordan, W. Edward, III [1 ]
Thomas, Lisa C. [1 ]
Kiel, Krystyna [6 ]
Peters, Christopher A. [5 ]
机构：
[1] Hematol & Oncol Associates NE PA, Dunmore, PA 18512 USA
[2] Loyola Univ, Med Ctr, Canc Survivorship Program, Dept Med Oncol, Maywood, IL 60153 USA
[3] Med Coll Georgia, MCG Clin Breast Canc Program, MCG Canc Ctr, Dept Med Hematol Oncol,Dev Therapeut Program, Augusta, GA 30912 USA
[4] Med Coll Georgia, MCG Div Hematol Oncol, Augusta, GA 30912 USA
[5] Commonwealth Med Coll, Dept Med, NE Radiat Oncol Ctr, Scranton, PA USA
[6] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
SEMINARS IN ONCOLOGY | 2010年 / 37卷 / 01期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; VIVO CHEMOSENSITIVITY; FOLLOW-UP; DOXORUBICIN; MENINGITIS; RECURRENCE; MASTECTOMY; RADIATION; SURVIVAL;
D O I：
10.1053/j.seminoncol.2009.12.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 10
页数：10
相关论文
共 50 条
  • [1] Breast cancer, neoadjuvant chemotherapy and residual disease
    Chavez-MacGregor, Mariana
    Gonzalez-Angulo, Ana Maria
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (07): : 461 - 467
  • [2] Breast cancer, neoadjuvant chemotherapy and residual disease
    Mariana Chávez-MacGregor
    Ana María González-Angulo
    [J]. Clinical and Translational Oncology, 2010, 12 : 461 - 467
  • [3] Dedicated breast PET for predicting residual disease after breast cancer neoadjuvant chemotherapy
    Sasada, S.
    Kadoya, T.
    Goga, N.
    Emi, A.
    Kajitani, K.
    Masumoto, N.
    Haruta, R.
    Kataoka, T.
    Okada, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer
    Peintinger, F.
    Kuerer, H. M.
    McGuire, S. E.
    Bassett, R.
    Pusztai, L.
    Symmans, W. F.
    [J]. BRITISH JOURNAL OF SURGERY, 2008, 95 (04) : 433 - 437
  • [5] Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Elder, E. A.
    Livasy, C.
    Donahue, E.
    Neelands, B. J.
    Patrick, A.
    Needham, M.
    Sarantou, T.
    Hadzikadic-Gusic, L.
    White, R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S53 - S53
  • [6] Racial Difference in Outcomes in Breast Cancer Patients with Residual Nodal Disease after Neoadjuvant Chemotherapy
    Johns, C.
    Kwon, Y. S.
    Rahimi, A. S.
    Liu, Y.
    Cauble, M.
    Alluri, P. G.
    Arbab, M.
    Nwachukwu, C. R.
    Kim, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E186 - E186
  • [7] Lymphopenia and clinical outcomes in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer
    Paulina M. Gutkin
    Margaret M. Kozak
    Rie von Eyben
    Kathleen C. Horst
    [J]. Cancer Causes & Control, 2020, 31 : 1021 - 1026
  • [8] Lymphopenia and clinical outcomes in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer
    Gutkin, Paulina M.
    Kozak, Margaret M.
    von Eyben, Rie
    Horst, Kathleen C.
    [J]. CANCER CAUSES & CONTROL, 2020, 31 (11) : 1021 - 1026
  • [9] Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
    Li, Zhijun
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [10] Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy
    Harter, Dawn
    O'Connor, Siobhan M.
    Hertel, Johann D.
    Calhoun, Benjamin C.
    [J]. HISTOPATHOLOGY, 2023, 83 (03) : 453 - 464
12345